Healthcare Industry News:  Solos Endoscopy 

Devices FDA

 News Release - August 16, 2006

Solos Endoscopy Files FDA Documents for the MastaScope(TM) and OvaScope(TM) Products

BOSTON, MA--(Healthcare Sales & Marketing Network)--Aug 16, 2006 -- Solos Endoscopy, Inc. (Other OTC:SLSE.PK ) is pleased to announce that the Company is filing with the FDA the documents requesting immediate market clearance on the recently acquired MastaScope(TM) and OvaScope(TM) product lines. Solos currently holds FDA market clearance for its line of breast endoscopes and will add the MastaScope(TM) to that line. In addition, Solos has a wide range of additional FDA cleared endoscopes in the market and will also request clearance on the OvaScope(TM). This will allow Solos Endoscopy to begin market introduction of its line of Women's Healthcare Products without delay.

Solos' line of breast endoscopes, which now includes the MastaScope(TM), are micro endoscopes that are utilized by physicians to observe the interior of women's breast milk ducts when examining for abnormalities, in particular, nipple discharge. The majority of breast cancers originate in the milk ducts. It is anticipated that these products and process of examination will assist in the early detection of breast cancer and holds the prospect of reducing unnecessary exploratory surgeries.

The Solos OvaScope(TM) endoscope transmits light and image through fiberoptic bundles rather than rigid lens-based systems of traditional endoscopes. This process permits direct vision to assist in the early detection of ovarian cancer. The data from tests demonstrated that the OvaScope(TM) identifies patients with peritoneal disease and has value in gynecological oncology surgery.

"Solos Endoscopy's existing endoscopic products and reputation in the industry will enhance the introduction of Solos' new line of Women's Healthcare products. As we develop these and other new products further, we will have the tools to give women a better preventative medical technology for Breast and Ovarian cancer," stated Robert Segersten, President of Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Source: Solos Endoscopy

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.